Co-Diagnostics Inc CODX

US Health Care

$1.44 ▼ -7.69% ($-0.12)

⬇️ Below Yest. Low 🎈 Low Float 🎢 High Beta 🗓️ Earnings Next Week

Open $1.60

Prev Close $1.56

Day Range $1.41 – $1.64

52W Range $1.26 – $46.50

Market Cap $7.60M

Beta 2.91

EPS (TTM) $-29.39

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2017-07-12
Shares Out.	5,280,000
Website	codiagnostics.com/ ↗
Phone	18014381036
Employees	115
Revenue	$145,954
Gross Profit	-$47,814
Net Income	-$9.1M
Free Cash Flow	-$29.0M
Total Assets	$21.5M
Total Liabilities	$5.5M
Equity	$16.0M

About Co-Diagnostics Inc

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Co-Diagnostics Inc is a publicly traded company under the ticker symbol CODX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.